Effects of gastric bypass on the GH/IGF-I axis in severe obesity - And a comparison with GH deficiency

European Journal of Endocrinology

Volumn 154, Issue 1, 2006, Pages 53-59

  Engström, Britt Edén ^a   Burman, Pia ^a   Holdstock, Camilla ^a   Öhrvall, Margareta ^a   Sundbom, Magnus ^a   Karlsson, F Anders ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISONE ACETATE; ESTROGEN; GLIPIZIDE; GLUCOSE; GROWTH HORMONE; INSULIN; LEVOTHYROXINE; METFORMIN; SOMATOMEDIN C; TESTOSTERONE;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; DISEASE SEVERITY; FEMALE; GLUCOSE HOMEOSTASIS; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HORMONE RELEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; STOMACH BYPASS; WEIGHT REDUCTION; AGE DISTRIBUTION; CIRCADIAN RHYTHM; COMPARATIVE STUDY; GROWTH HORMONE RELEASE; HORMONE DETERMINATION; PATIENT SELECTION; PREOPERATIVE EVALUATION; REFERENCE VALUE; ROUX Y ANASTOMOSIS;

ADULT; BODY MASS INDEX; FEMALE; GASTRIC BYPASS; GLUCOSE; HOMEOSTASIS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OBESITY;

EID: 32844474966     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02069     Document Type: Article

References (55)

1. Procopio M, Maccario M, Savio P, Valetto MR, Aimaretti G, Grottoli S, Oleandri SE, Baffoni C, Tassone F, Arvat E, Camanni F & Ghigo E. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism. Minerva Endocrinologica 1999 24 107-111.
2. Alvarez P, Isidro L, Leal-Cerro A, Casanueva FF, Dieguez C & Cordido F. Effect of withdrawal of somatostatin plus GH-releasing hormone stimulus of GH secretion in obesity. Clinical Endocrinology 2002 56 487-492.
3. Cordido F, Alvarez-Castro P, Isidro MI, Casanueva FF & Dieguez C. Comparison between insulin tolerance test, growth hormone releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients. European Journal of Endocrinology 2003 149 117-122.
4. Park MJ, Kim HS, Kang JH, Kim DH & Chung CY. Serum levels of insulin-like growth factor (IGF)-I, free IGF-I, IGF binding (IGFBP)-1, IGFBP-3 and insulin in obese children. Journal of Pediatric Endocrinology and Metabolism 1999 12 139-144.
5. Ballerini MG, Ropelato MG, Domene HM, Pennisi P, Heinrich JJ & Jasper HG. Differential impact of simple childhood obesity on the components of the hormone-insulin-like growth factor (IGF)-IGF binding proteins axis. Journal of Pediatric Endocrinology and Metabolism 2004 17 749-757.
6. Attia N, Tamberlane WV, Heptulla R, Maggs D, Grozman A, Sherwin RS & Caprio S. The metabolic syndrome and insulin-like growth factor I regulation in adult obesity. Journal of Clinical Endocrinology and Metabolism 1998 83 1467-1471.
7. Állemand D, Schmidt S, Rousson V, Brabant G, Gasser T & Gruters A. Associations between body mass, leptin, IGF-I and circulating adrenal androgens in children with obesity and premature adrenarche. European Journal of Endocrinology 2002 146 537-543.
8. Kaytor EN, Zhu JL, Pao CI & Phillips LS. Physiologic concentrations of insulin promote binding of nuclear proteins to the insulin-like growth factor I gene. Endocrinology 2001 142 1041-1049.
9. Hoffman DM, O'Sullivan AJ, Baxter RC & Ho KK. Diagnosis of growth hormone deficiency in adults. Lancet 1994 343 1064-1068.
10. Bates AS, Evans AJ, Jones P & Clayton RN. Assessment of GH status in adults with GH deficiency using serum growth hormone, serum insulin-like growth factor-I and urinary growth hormone excretion. Clinical Endocrinology 1995 42 425-430.
11. Thissen JP, Ketelslegers JM & Maiter D. Use of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in the diagnosis of acromegaly and growth hormone deficiency in adults. Growth Regulation 1996 6 222-229.
12. Svensson J, Johannsson G & Bengtsson BA. Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test. Clinical Endocrinology 1997 46 579-586.
13. Hilding A, Hall K, Wivall-Helleryd IL, Saaf M, Melin AL & Thoren M. Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. Journal of Clinical Endocrinology and Metabolism 1999 84 2013-2019.
14. Lieberman SA, Oberoi AL, Gilkison CR, Masel BE & Urban RJ. Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury. Journal of Clinical Endocrinology and Metabolism 2001 86 2752-2756.
15. Aimaretti G, Ambrosio MR, Di Somma C, Fusco A, Cannavo S, Gasperi M, Scaroni C, De Marinis L, Benvenga S, degli Uberti EC, Lombardi G, Mantero F, Martino E, Giardano G & Ghigo E. Traumatic brain injury and subarachnoidal haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clinical Endocrinology 2004 61 320-326.
16. Lissett CA, Saleem S, Rahim A, Brennan BM & Shalet SM. The impact of irradiation on growth hormone responsiveness to provocative agents is stimulus dependent: results in 161 individuals with radiation damage to the somatotropic axis. Journal of Clinical Endocrinology and Metabolism 2001 86 663-668.
17. Didi M, Didcock E, Davies HA, Ogilvy Stuart AL, Wales JK & Shalet SM. High incidence of obesity in young adults after treatment of acute lymphoblastic leukaemia in childhood. Journal of Pediatrics 1995 127 63-67.
18. Sklar CA, Mertens AC, Walter A, Mitchell D, Nesbit ME, O'Leary M, Hutchinson R, Meadows AT & Robison LL. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukaemia: role of cranial irradiation. Medical and Pediatric Oncology 2000 35 91-95.
19. Winer LM, Shaw MA & Baumann G. Basal plasma growth hormone levels in man: new evidence for rhytmicity of growth hormone secretion. Journal of Clinical Endocrinology and Metabolism 1990 70 1678-1686.
20. van den Berg G, Veldhuis JD, Frölich M & Roelfsema F. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. Journal of Clinical Endocrinology and Metabolism 1996 81 2460-2467.
21. Pincus SM, Gevers EF, Robinson ICA, van den Berg G, Roelfsema F, Hartman ML & Veldhuis JD. Females secrete growth hormone with more process irregularity than males in both humans and rats. American Journal of Physiology 1996 270 E107-E115.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessments insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
23. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 2005 28 S4-S36.
24. Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Hilsted J & Skakkebaek NE. Massive weight loss restores 24-hour growth hormone release and serum insulin-like growth factor-I levels in obese subjects. Journal of Clinical Endocrinology and Metabolism 1995 80 1407-1415.
25. De Marinis L, Bianchi A, Mancini A, Gentilella R, Perelli M, Giampietro A, Porcelli T, Tilaro L, Fusco A, Valle D & Tacchino RM. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationship with insulin and body composition. Journal of Clinical Endocrinology and Metabolism 2004 89 174-180.
26. Maccario M, Aimaretti G, Grottoli S, Gauna C, Tassone F, Corneli C, Rossetto R, Wu Z, Strasburger CJ & Ghigo E. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency. International Journal of Obesity and Related Metabolic Disorders 2001 25 1233-1239.
27. Misra M, Miller KK, Bjornson J, Hackman A, Aggarwal A, Chung J, Herzog DB, Johnson MI & Klibanski A. Alterations in growth hormone secretory dynamics in adolescence with anorexia nervosa and effects on bone metabolism. Journal of Clinical Endocrinology and Metabolism 2003 88 5615-5623.
28. Jones JL & Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 1995 16 3-34.
29. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W & Le Roith D. Liver-specific IGF-I gene deletion leads to muscle insulin insensitivity. Diabetes 2001 50 1110-1118.
30. Juul A, Scheike T, Davidsen M, Gyllenbrog J & Jorgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002 106 939-944.
31. Vasan RS, Sullivan LM, D'Agostino RB, Roubenoff R, Harris T, Sawyer DB, Levy D & Wilson PW. Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Annals of Internal Medicine 2003 139 642-648.
32. Laughlin GA, Barrett-Connor E, Criqui MH & Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. Journal of Clinical Endocrinology and Metabolism 2004 89 114-120.
33. Sandhu MS, Dunger DB & Giovannucci EL. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002 359 1740-1745.
34. Fisker S, Vahl N, Jorgensen JO, Christiansen JS & Orskov H. Abdominal fat determines growth hormone-binding protein levels in healthy non-obese adults. Journal of Clinical Endocrinology and Metabolism 1997 82 123-128.
35. Hochberg Z, Hertz P, Colin V, Ish-Shalom S, Yeshurun D & Youdim MB. The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism 1992 41 106-112.
36. Maccario M, Tassone F, Gauna C, Oleandri SE, Aimaretti G, Procopio M, Grottoli S, Pflaum CD, Strasburger CJ & Ghigo E. Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of the sensitivity to GH. European Journal of Endocrinology 2001 144 251-256.
37. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S & Orskov H. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metabolism Research and Reviews 1999 15 314-322.
38. Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE & Orskov H. Free insulin-like growth factor in human obesity. Metabolism 1995 44 37-44.
39. Gianotti L, Pivetti S, Lanfranco F, Tassone F, Vittori E, Rossetto R, Gauna C, Destefanis S, Grottoli S, De Giorgi R, Gai V, Ghigo E & Maccario M. Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnoea syndrome. Journal of Clinical Endocrinology and Metabolism 2002 87 5052-5057.
40. Buijs MM, Romijn JA, Burggraaf J, De Kam MI, Cohen AF, Frolich M, Stellaard F, Meinders AE & Pijl H. Growth hormone blunts protein oxidation and promotes protein turnover to a similar extent in abdominally obese and normal-weight women. Journal of Clinical Endocrinology and Metabolism 2002 87 5668-5674.
41. Seng G, Galgoti C, Louisy P, Drouin P & Debry G. Metabolic effects of a single administration of growth hormone on lipid and carbohydrate metabolism in normal-weight and obese subjects. American Journal of Clinical Nutrition 1989 50 1348-1354.
42. Phillip M, Moran O & Lazar L. Growth without growth hormone. Journal of Paediatric Endocrinology and Metabolism 2002 15 1267-1272.
43. Toogood AA. Growth hormone (GH) status and body composition in normal ageing and in elderly adults with GH deficiency. Hormone Research 2003 60 105-111.
44. Iranmesh A, Lizaralde G & Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. Journal of Clinical Endocrinology and Metabolism 1991 75 530-535.
45. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL & Thorner MO. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. Journal of Clinical Endocrinology and Metabolism 1987 64 51-58.
46. Edén Engström B, Karlsson FA & Wide L. Gender differences in diurnal growth hormone and epinephrine values in young adults during ambulation. Clinical Chemistry 1999 45 1235-1239.
47. Edén Engström B, Karlsson FA & Wide L. Marked gender differences in ambulatory morning growth hormone values in young adults. Clinical Chemistry 1998 44 1289-1295.
48. Maccario M, Gauna C, Procopio M, Di Vito L, Rossetto R, Oleandri SE, Grottoli S, Ganzaroli C, Aimaretti G & Ghigo E. Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I and the GH response to GHRH + arginine test. Journal of Endocrinological Investigation 1999 22 424-429.
49. Bonert VS, Elashoff JD, Barnett P & Melmed S. Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency. Journal of Clinical Endocrinology and Metabolism 2004 89 3397-3401.
50. Ho KK & Hoffman DM. Defining growth hormone deficiency in adults. Metabolism 1995 44 (Suppl. 4) 91-96.
51. Ho KK. Diagnosis of adult GH deficiency. Lancet 2000 356 1125-1126.
52. Corneli G, Di Somma C, Baldelli R, Rovere S, Gasco V, Croce CG, Grottoli S, Maccario M, Colao A, Lombardi G, Ghigo E, Camanni F & Aimaretti G. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. European Journal of Endocrinology 2005 153 257-264.
53. Hajina SV, van Dam PS, de Vries WR, Maitimu-Smeele I, Dieguez C, Casanueva FF & Koppeschaar HPF. The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese men. European Journal of Endocrinology 2005 152 575-580.
54. Burman P, Johansson AG, Siegbahn A, Vessby B & Karlsson FA. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. Journal of Clinical Endocrinology and Metabolism 1997 82 550-555.
55. Edén Engström B, Burman P, Johansson AG & Wide L. Effects of short-term administration of growth hormone in healthy young men, women, and women taking oral contraceptives. Journal of Internal Medicine 2000 247 570-578.